BioCardia, Inc. Class of Warrant or Right, Outstanding
BioCardia, Inc. (BCDA) had Class of Warrant or Right, Outstanding of 7.85 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-12
- 2026-06-30: Class of Warrant or Right, Outstanding 7.85M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 7.88M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 7.94M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 7.95M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 7.85M shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 7.88M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 7.94M shares 10-Q · filed 2026-08-12 | |
| 2025-09-30 | 7.95M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 3.15M shares 10-Q/A · filed 2025-10-29 | |
| 2025-03-31 | 2.47M shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 2.47M shares 10-K · filed 2026-03-24 | |
| 2024-09-30 | 2.47M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 208.99K shares 10-Q · filed 2024-08-13 | |
| 2023-12-31 | 141.89K shares 10-K · filed 2026-03-24 | 2.13M shares 10-K · filed 2024-03-27 |
| 2023-09-30 | 3.13M shares 10-Q · filed 2024-05-14 | 2.42M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 2.42M shares 10-Q · filed 2023-08-09 | |
| 2023-03-31 | 2.42M shares 10-Q · filed 2023-05-10 | |
| 2022-12-31 | 161.65K shares 10-K · filed 2025-03-26 | 2.42M shares 10-K · filed 2023-03-29 |
| 2022-09-30 | 2.42M shares 10-Q · filed 2022-11-09 | |
| 2022-06-30 | 2.42M shares 10-Q · filed 2022-08-10 | |
| 2022-03-31 | 2.42M shares 10-Q · filed 2022-05-11 | |
| 2021-12-31 | 2.42M shares 10-K · filed 2023-03-29 | |
| 2021-09-30 | 2.42M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 2.42M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 2.42M shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 2.42M shares 10-K · filed 2022-03-29 | |
| 2020-09-30 | 2.44M shares 10-Q · filed 2020-11-10 | |
| 2020-06-30 | 2.44M shares 10-Q · filed 2020-08-13 | |
| 2020-03-31 | 2.44M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 2.44M shares 10-K · filed 2021-03-30 | 2.44M shares 10-K · filed 2020-04-09 |
| 2019-09-30 | 2.44M shares 10-Q · filed 2019-11-19 | |
| 2018-12-31 | 296.30K shares 10-K · filed 2020-04-09 | |
| 2016-12-31 | 2.33M shares 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |